Anti-LMO2 antibody - ChIP Grade (ab72841)


  • Product nameAnti-LMO2 antibody - ChIP Grade
    See all LMO2 primary antibodies
  • Description
    Rabbit polyclonal to LMO2 - ChIP Grade
  • Tested applicationsSuitable for: ChIP, WBmore details
  • Species reactivity
    Reacts with: Mouse, Human
    Predicted to work with: Rat, Cow, Zebrafish
  • Immunogen

    Synthetic peptide corresponding to a region within N terminal residues 1-100 of human LMO2. [Swiss-Prot# P25791]

  • Positive control
    • Ramos Whole Cell Extracts.


Associated products


Our Abpromise guarantee covers the use of ab72841 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
ChIP Use at an assay dependent dilution.
WB Use a concentration of 0.5 µg/ml. Detects a band of approximately 24 kDa (predicted molecular weight: 18 kDa).


  • FunctionActs with TAL1/SCL to regulate red blood cell development. Also acts with LDB1 to maintain erythroid precursors in an immature state.
  • Involvement in diseaseNote=A chromosomal aberration involving LMO2 may be a cause of a form of T-cell acute lymphoblastic leukemia (T-ALL). Translocation t(11,14)(p13;q11) with TCRD.
  • Sequence similaritiesContains 2 LIM zinc-binding domains.
  • DomainThe second LIM zinc-binding domain interacts with KDM5A.
  • Cellular localizationNucleus.
  • Information by UniProt
  • Database links
  • Alternative names
    • Cysteine rich protein TTG 2 antibody
    • Cysteine rich protein TTG2 antibody
    • Cysteine-rich protein TTG-2 antibody
    • LIM domain only 2 (rhombotin like 1) antibody
    • LIM domain only 2 antibody
    • LIM domain only protein 2 antibody
    • LMO 2 antibody
    • LMO-2 antibody
    • lmo2 antibody
    • RBTN 2 antibody
    • RBTN L1 antibody
    • RBTN2 antibody
    • RBTN2_HUMAN antibody
    • RBTNL 1 antibody
    • RBTNL1 antibody
    • RHOM 2 antibody
    • RHOM2 antibody
    • Rhombotin 2 antibody
    • Rhombotin like 1 antibody
    • Rhombotin-2 antibody
    • Rhombotin2 antibody
    • T cell translocation gene 2 antibody
    • T cell translocation protein 2 antibody
    • T-cell translocation protein 2 antibody
    • TTG 2 antibody
    • TTG2 antibody
    see all

Anti-LMO2 antibody - ChIP Grade images

  • Anti-LMO2 antibody - ChIP Grade (ab72841) at 0.5 mg/ml + Ramos whole cell lysate

    Predicted band size : 18 kDa
    Observed band size : 24 kDa (why is the actual band size different from the predicted?)
  • ab72841 used undiluted in ChIP analysis, incubated for 16 hours at 4°C.
    Nuclear cell lysate prepared from mouse haematopoietic progenitor cell line HPC-7.
    Cross-linking (X-ChIP) performed by using 1% formaldehyde for 10 minutes.
    Detection step: Real time PCR.
    Negative control: A regultory element which is an open region of chromatin but is devoid of this transcription factor.

    See Abreview

References for Anti-LMO2 antibody - ChIP Grade (ab72841)

ab72841 has not yet been referenced specifically in any publications.

Product Wall

Thank you for contacting us.

The antibody ab26096 has not been tested in Chip application so I am sorry we are unable to confirm its use. This however does not means the antibody cannot be used it only means we do not have tested data. If you ...

Read More
Abcam guarantees this product to work in the species/application used in this Abreview.
Application ChIP
Sample Mouse Cell lysate - nuclear (haematopoietic progenitor cell line HPC-7)
Specification haematopoietic progenitor cell line HPC-7
Type Cross-linking (X-ChIP)
Duration of cross-linking step: 10 minute(s) and 0 second(s)
Specification of the cross-linking agent: 1% formaldehyde
Detection step Real-time PCR
Positive control i) a competitors antibody known to work
ii) a regulatory element known to bind this transcription factor
Negative control a regultory element which is an open region of chromatin but is devoid of this transcription factor

Abcam user community

Verified customer

Submitted Feb 18 2010